Current Drug Discovery Technologies

Editor-in-Chief

Vladimir P. Torchilin
(68301 citations)
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Open Access Articles

Potential Fatty Acid as Antibacterial Agent Against Oral Bacteria of Streptococcus mutans and Streptococcus sanguinis from Basil (Ocimum americanum): In vitro and In silico Studies open Access plus

Volume: 18   Issue: 4
Pp: 532-541
Yetty Herdiyati, Yonada Astrid, Aldina Amalia Nur Shadrina, Ika Wiani, Mieke Hemiawati Satari and Dikdik Kurnia*
DOI:10.2174/1570163817666200712171652

Synthesis, Cytotoxicity Evaluation and Molecular Docking of Fluorine Containing Hexahydroquinoline-3-Carbonitrile Derivatives open Access plus

Volume: 18  
Pp: 1-11
Nishith Teraiya*, Subhas Karki and Ashlesha Chauhan
DOI:10.2174/1570163817666201229154848

The Development of New Low-Molecular-Weight Factor Xa Inhibitors that are Potential Anticoagulants open Access plus

Volume: 18  
Pp: 1-8
Dmitry G. Tovbin, Dmitry N. Tarasov, Dmitry V. Malakhov, Natalia A. Tserkovnikova, Arseniy V. Aybush and Natalia N. Drozd*
DOI:10.2174/1568009621666210224104940

Structure-Based Docking Studies of GLUT4 Towards Exploring Selected Phytochemicals from Solanum xanthocarpum as a Therapeutic Target for the Treatment of Cancer open Access plus

Volume: 16   Issue: 4
Pp: 406-416
Babatunji Emmanuel Oyinloye*, Tayo Alex Adekiya, Raphael Taiwo Aruleba, Oluwafemi Adeleke Ojo and Basiru Olaitan Ajiboye
DOI:10.2174/1570163815666180801152110

The Modulatory Effect of Lead Drug Candidates on Inflammatory Gene Expression in Sepsis: A Mini-Review open Access plus

Volume: 16   Issue: 1
Pp: 48-56
Samuel Mawuli Adadey*, Michael Bright Yakass, Seth Agyemang and Samuel Duodu
DOI:10.2174/1570163815666180227162926

Date Palm (Phoenix dactylifera): Novel Findings and Future Directions for Food and Drug Discovery open Access plus

Volume: 16   Issue: 1
Pp: 2-10
Ali H. El-Far*, Babatunji E. Oyinloye, Masood Sepehrimanesh, Mahmoud A. Gab Allah, Ibrahim Abu-Reidah, Hazem M. Shaheen, Iman Razeghian-Jahromi, Abd el-wahab A. Alsenosy, Ahmed E. Noreldin, Soad K. Al Jaouni and Shaker A. Mousa*
DOI:10.2174/1570163815666180320111937

The Development of New Factor Xa Inhibitors Based on Amide Synthesis open Access plus

Volume: 15   Issue: 4
Pp: 335-350
Dmitry N. Tarasov, Dmitry G. Tovbin, Dmitry V. Malakhov, Arseniy V. Aybush, Natalia A. Tserkovnikova, Marina I. Savelyeva, Dmitry A. Sychev, Natalia N. Drozd* and Alla Y. Savchenko
DOI:10.2174/1570163815666180215114732

Pimping up Drugs Recovered, Superannuated and Under Exploited Drugs - An Introduction to the Basics of Drug Reprofiling open Access plus

Volume: 14   Issue: 2
Pp: 121-126
Suzanne J. Dilly* and George S. Morris
DOI:10.2174/1570163814666170117120005

Possible Anticancer Mechanisms of Some Costus speciosus Active Ingredients Concerning Drug Discovery open Access plus

Volume: 13   Issue: 3
Pp: 123-143
Ali H. El-Far, Faried A. Badria and Hazem M. Shaheen
DOI:10.2174/1570163813666160802154403

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma open Access plus

Volume: 13   Issue: 2
Pp: 68-76
Akash Verma, Akhil Chopra, Yeo W. Lee, Lavina D. Bharwani, Atasha B. Asmat, Dokeu B.A Aneez, Fazuludeen A. Akbar, Albert Y.H. Lim, Sanjay H. Chotirmall and John Abisheganaden
DOI:10.2174/1570163813666160524142846